| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Seyed-Mohammad Fereshtehnejad, Dorota Religa, Eric Westman, Dag Aarsland, Johan Lökk, Maria Eriksdotte. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatric disease and treatment. vol 9. 2013-07-12. PMID:23847419. |
whether dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd) should be considered as one entity or two distinct conditions is a matter of controversy. |
2013-07-12 |
2023-08-12 |
Not clear |
| Seyed-Mohammad Fereshtehnejad, Dorota Religa, Eric Westman, Dag Aarsland, Johan Lökk, Maria Eriksdotte. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatric disease and treatment. vol 9. 2013-07-12. PMID:23847419. |
the aim of this study was to compare the characteristics of dlb and pdd patients using data from the swedish dementia quality registry (svedem). |
2013-07-12 |
2023-08-12 |
Not clear |
| Tatyana Verina, Jay S Schneider, Tomás R Guilart. Manganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primates. Toxicology letters. vol 217. issue 3. 2013-07-01. PMID:23262390. |
they include parkinson's disease (pd), dementia with lewy bodies (dlb), and multiple system atrophy (msa). |
2013-07-01 |
2023-08-12 |
Not clear |
| Malin Wennström, Yulia Surova, Sara Hall, Christer Nilsson, Lennart Minthon, Fredrik Boström, Oskar Hansson, Henrietta M Nielse. Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PloS one. vol 8. issue 1. 2013-07-01. PMID:23308173. |
neurosin is a protease that in vitro degrades α-synuclein, the main constituent of lewy bodies found in brains of patients with synucleinopathy including parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2013-07-01 |
2023-08-12 |
Not clear |
| Malin Wennström, Yulia Surova, Sara Hall, Christer Nilsson, Lennart Minthon, Fredrik Boström, Oskar Hansson, Henrietta M Nielse. Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PloS one. vol 8. issue 1. 2013-07-01. PMID:23308173. |
to investigate potential links between neurosin and its substrate α-synuclein in vivo we used a commercially available sandwich elisa and an in-house developed direct elisa to quantify csf levels of α-synuclein and neurosin in patients diagnosed with dlb, pd and pd dementia (pdd) versus ad patients and non-demented controls. |
2013-07-01 |
2023-08-12 |
Not clear |
| Hiroshi Hayashi, Shinobu Kawakatsu, Akihito Suzuki, Yuzuru Shibuya, Ryota Kobayashi, Chikako Sato, Koichi Otan. Application of the VSRAD, a specific and sensitive voxel-based morphometry, to comparison of entorhinal cortex atrophy between dementia with Lewy bodies and Alzheimer's disease. Dementia and geriatric cognitive disorders. vol 34. issue 5-6. 2013-06-24. PMID:23208522. |
previous studies using magnetic resonance imaging (mri) showed that dementia with lewy bodies (dlb) had less atrophy in some medial temporal structures than alzheimer's disease (ad). |
2013-06-24 |
2023-08-12 |
Not clear |
| Alex Iranzo, Eduard Tolosa, Ellen Gelpi, José Luis Molinuevo, Francesc Valldeoriola, Mónica Serradell, Raquel Sanchez-Valle, Isabel Vilaseca, Francisco Lomeña, Dolores Vilas, Albert Lladó, Carles Gaig, Joan Santamari. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. The Lancet. Neurology. vol 12. issue 5. 2013-06-24. PMID:23562390. |
we postulated that idiopathic rapid-eye-movement (rem) sleep behaviour disorder (irbd) represents the prodromal phase of a lewy body disorder and that, with sufficient follow-up, most cases would eventually be diagnosed with a clinical defined lewy body disorder, such as parkinson's disease (pd) or dementia with lewy bodies (dlb). |
2013-06-24 |
2023-08-12 |
Not clear |
| Richard A Armstron. A quantitative study of abnormally enlarged neurons in cognitively normal brain and neurodegenerative disease. Clinical neuropathology. vol 32. issue 2. 2013-06-20. PMID:23073168. |
the data suggest: (1) that a cl/nd ≥ 3.0 may be a useful morphological criterion for defining aen, and (2) aen were most numerous in pid and corticobasal degeneration (cbd) and least abundant in ad and in dementia with lewy bodies (dlb). |
2013-06-20 |
2023-08-12 |
Not clear |
| Winnie C Pao, Bradley F Boeve, Tanis J Ferman, Sioung-Chi Lin, Glenn E Smith, David S Knopman, Neill R Graff-Radford, Ronald C Petersen, Joseph E Parisi, Dennis W Dickson, Michael H Silbe. Polysomnographic findings in dementia with Lewy bodies. The neurologist. vol 19. issue 1. 2013-06-07. PMID:23269098. |
the clinical features of dementia with lewy bodies (dlb) during wakefulness are well known. |
2013-06-07 |
2023-08-12 |
Not clear |
| Toshiya Fukui, Yoshiyuki Oowan, Takahiro Yamazaki, Ryuta Kinn. Prevalence and clinical implication of microbleeds in dementia with lewy bodies in comparison with microbleeds in Alzheimer's disease. Dementia and geriatric cognitive disorders extra. vol 3. issue 1. 2013-06-07. PMID:23741227. |
cerebral microbleeds (mbs) have been well investigated in alzheimer's disease (ad), but not very extensively in non-ad dementias or in dementia with lewy bodies (dlb). |
2013-06-07 |
2023-08-12 |
Not clear |
| Melanie Zupancic, Aman Mahajan, Kamna Hand. Dementia with lewy bodies: diagnosis and management for primary care providers. The primary care companion for CNS disorders. vol 13. issue 5. 2013-06-04. PMID:22295275. |
the purpose of this review is to aid primary care providers in distinguishing dementia with lewy bodies (dlb) from alzheimer's disease and from parkinson's disease with dementia. |
2013-06-04 |
2023-08-12 |
Not clear |
| Alessandra Marcone, Valentina Garibotto, Rosa Maria Moresco, Ioana Florea, Andrea Panzacchi, Assunta Carpinelli, Jere R Virta, Marco Tettamanti, Barbara Borroni, Alessandro Padovani, Alessandra Bertoldo, Karl Herholz, Juha O Rinne, Stefano Francesco Cappa, Daniela Peran. [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis. Journal of Alzheimer's disease : JAD. vol 31. issue 2. 2013-06-04. PMID:22596267. |
non-invasive approaches for positron emission tomography (pet) parametric imaging of acetylcholinesterase (ache) activity have been developed and applied to the investigation of dementia, mainly alzheimer's disease (ad), but also dementia with lewy bodies (dlb), not including, however, patients in the early disease stage. |
2013-06-04 |
2023-08-12 |
human |
| Annachiara Cagnin, Francesca Gnoato, Nela Jelcic, Silvia Favaretto, Giulia Zarantonello, Mario Ermani, Mauro Da. Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry. vol 84. issue 5. 2013-05-31. PMID:23264688. |
the presence of recurrent complex visual hallucinations (vhs) is a core feature of dementia with lewy bodies (dlb). |
2013-05-31 |
2023-08-12 |
Not clear |
| b' Mart\\xc3\\xad Colom-Cadena, Ellen Gelpi, Mar\\xc3\\xada J Mart\\xc3\\xad, Sara Charif, Oriol Dols-Icardo, Rafael Blesa, Jordi Clarim\\xc3\\xb3n, Alberto Lle\\xc3\\xb. MAPT H1 haplotype is associated with enhanced \\xce\\xb1-synuclein deposition in dementia with Lewy bodies. Neurobiology of aging. vol 34. issue 3. 2013-05-24. PMID:22819391.' |
our aim was to investigate the relationship between mapt haplotypes and pathologic aggregates of tau and α-synuclein in pathologically confirmed cases of dementia with lewy bodies (dlb). |
2013-05-24 |
2023-08-12 |
Not clear |
| Sean J Colloby, John-Paul Taylor, Christopher M Davison, Jim J Lloyd, Michael J Firbank, Ian G McKeith, John T O'Brie. Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 33. issue 4. 2013-05-23. PMID:23361395. |
we examined (99m)tc-exametazime brain blood flow single-photon emission computed tomography (spect) images using a spatial covariance analysis (sca) approach to assess its diagnostic value in distinguishing dementia with lewy bodies (dlb) from alzheimer's disease (ad). |
2013-05-23 |
2023-08-12 |
Not clear |
| James O'Donovan, Rosie Watson, Sean J Colloby, Michael J Firbank, Emma J Burton, Robert Barber, Andrew M Blamire, John T O'Brie. Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging? International psychogeriatrics. vol 25. issue 1. 2013-05-17. PMID:22809815. |
dementia with lewy bodies (dlb) is associated with less temporal lobe atrophy than ad, though posterior cortical atrophy may be greater. |
2013-05-17 |
2023-08-12 |
Not clear |
| Akio Sekigawa, Masayo Fujita, Kazunari Sekiyama, Yoshiki Takamatsu, Taku Hatano, Edward Rockenstein, Albert R La Spada, Eliezer Masliah, Makoto Hashimot. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein. Molecular brain. vol 5. 2013-05-15. PMID:23013868. |
axonopathy is critical in the early pathogenesis of neurodegenerative diseases, including parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2013-05-15 |
2023-08-12 |
mouse |
| Saori Odagiri, Kunikazu Tanji, Fumiaki Mori, Yasuo Miki, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayash. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochemical and biophysical research communications. vol 430. issue 1. 2013-05-14. PMID:23159615. |
previous immunohistochemical studies have shown that hdac6 accumulates in lewy bodies in parkinson's disease and dementia with lewy bodies (dlb) as well as in glial cytoplasmic inclusions in multiple system atrophy (msa). |
2013-05-14 |
2023-08-12 |
Not clear |
| Richard A Armstron. Visual signs and symptoms of dementia with Lewy bodies. Clinical & experimental optometry. vol 95. issue 6. 2013-05-07. PMID:22812926. |
dementia with lewy bodies ('lewy body dementia' or 'diffuse lewy body disease') (dlb) is the second most common form of dementia to affect elderly people, after alzheimer's disease. |
2013-05-07 |
2023-08-12 |
Not clear |
| Walter Maetzler, Youyong Tian, Stephanie Maria Baur, Tina Gauger, Bartholomäus Odoj, Benjamin Schmid, Claudia Schulte, Christian Deuschle, Susanna Heck, Anja Apel, Arthur Melms, Thomas Gasser, Daniela Ber. Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia. PloS one. vol 7. issue 10. 2013-05-07. PMID:23133543. |
parkinson's disease (pd) without (non-demented, pdnd) and with dementia (pdd), and dementia with lewy bodies (dlb) are subsumed under the umbrella term lewy body disorders (lbd). |
2013-05-07 |
2023-08-12 |
Not clear |